Journal Of Clinical Oncology (jco) Podcast
Can We Simplify the Treatment of Myelofibrosis?
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:08:51
- Mas informaciones
Informações:
Sinopsis
In this randomized trial, momelotinib was non-inferior to ruxolitinib for spleen response but was less effective in controlling symptoms. Related Article: SIMPLIFY-1: A Phase III Randomized Trial of Momelotinib Versus Ruxolitinib in Janus Kinase Inhibitor–Naïve Patients With Myelofibrosis
